Stiefel Laboratories

Gavin Corcoran, M.D., FACP, has been appointed to the newly created position of chief scientific officer at Stiefel Laboratories. The position was created to “reinforce the already critical role played by the R&D organization and the unity between all R&D departments,” according to a company statement. It also will further strengthen the collaboration among Stiefel’s five R&D facilities around the world.

Mr. Corcoran will oversee global scientific and operational activities related to product development and support; medical and scientific affairs; clinical and preclinical research; pharmacovigilance; portfolio planning; and regulatory affairs.

“Gavin’s promotion to chief scientific officer is a testament to the wonderful work he has done for Stiefel since he came on board,” said Brent Stiefel, executive vice president, Global Corporate Development and Product Portfolio. “We chose him to lead our R&D division because his vast experience along with his keen understanding of the industry arms him with the insight that will improve today’s skin treatments and develop tomorrow’s solutions.”

Prior to his promotion, Corcoran served as senior vice president, Global R&D. He joined Stiefel in 2005 as senior vice president, Global Clinical and Regulatory Affairs and has been a driving force in advancing the expansion of a world-class, global research and development organization. With this promotion, Corcoran will remain in Stiefel’s R&D headquarters in Research Triangle Park and continue to report to Brent Stiefel.